On April 1, 2026, China implemented a landmark national standard: Classification and Determination of TCM Constitution. Although designated as a recommended rather than mandatory standard, it represents a major step in modernizing traditional Chinese medicine (TCM) by converting traditional constitution theory into a clear, measurable and clinically practical framework. By clarifying the relationship between constitution, disease, and pattern differentiation, the standard strengthens professional credibility, supports research, and enhances patient-centered treatment.
Jing Struve
Jing Struve has more than 16 years of experience in the industry and is the executive director at Farlong Pharmaceutical. Inspired by the healing power of ancient remedies, Jing is passionate about applying these remedies in concert with modern technology to assist people in living healthier lives. Farlong sells over 400 supplements and ingredients, which it produces from seed to shelf beginning at its GAP farm in Yunnan Province, China, from which 75 percent of the world's medicinal botanicals originate. For more information, visit Farlong.com.